Propria LLC is a leading provider of in vitro cardiac contractility testing services, specializing in disease models and new therapeutics. Their comprehensive contractile profiling and functional cardiac reserve services offer deeper insights into cardiac function and adaptability, enabling scientists and pharmaceutical companies to better predict human pharmacology.
With their innovative human engineered heart tissues (hEHTs), Propria has revolutionized contractile profiling by creating a system that closely mimics the cellular composition and twitch kinetics of the adult human myocardium. Their thin and ribbon-like hEHTs, combined with specialized instrumentation and rigorous quality control metrics, ensure accurate and reliable data for longer-term contractility testing. Backed by a team of highly-trained PhD-level scientists, Propria provides not only comprehensive contractility data but also expert analysis and interpretation in the field of cardiac muscle physiology.
Generated from the website